Paper11568993
Efficacy and safety of aerosolized tobramycin in cystic fibrosis.
Pai VB and 1 other. Pediatr Pulmonol, 2001. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Papers, record 11568993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11568993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Tobramycin | Major topic |
| Administration, Inhalation | |
| Adolescent | |
| Aerosols | |
| Biological Availability | |
| Child | |
| Child, Preschool | |
| Consumer Product Safety | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Male | |
| Nebulizers and Vaporizers | |
| Sensitivity and Specificity | |
| Treatment Outcome |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42554208 | Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42554208 | PubMed |
| 38651896 | Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection. | mBio | 2024 | https://conductscience.org/library/papers/38651896 | PubMed |
| 35281576 | N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms Formed by Clinical Strains of Pseudomonas aeruginosa Isolated from Sputum of Cystic Fibrosis Patients. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/35281576 | PubMed |
| 34112170 | In vitro delivery efficiencies of nebulizers for different breathing patterns. | Biomed Eng Online | 2021 | https://conductscience.org/library/papers/34112170 | PubMed |
| 32671191 | Mode of nitric oxide delivery affects antibacterial action. | ACS Biomater Sci Eng | 2020 | https://conductscience.org/library/papers/32671191 | PubMed |
| 31360698 | Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis. | ERJ Open Res | 2019 | https://conductscience.org/library/papers/31360698 | PubMed |
| 29904366 | Bilateral Vestibular Weakness. | Front Neurol | 2018 | https://conductscience.org/library/papers/29904366 | PubMed |
| 29517998 | Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. | Pharmaceuticals (Basel) | 2018 | https://conductscience.org/library/papers/29517998 | PubMed |
| 29066797 | Destination of aminoglycoside antibiotics in the 'post-antibiotic era'. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/29066797 | PubMed |
| 27716346 | Fundamentals of aerosol therapy in critical care. | Crit Care | 2016 | https://conductscience.org/library/papers/27716346 | PubMed |
| 24673698 | Inhaled antibiotics for lower airway infections. | Ann Am Thorac Soc | 2014 | https://conductscience.org/library/papers/24673698 | PubMed |
| 22919396 | Sinonasal manifestations in cystic fibrosis. | Int J Otolaryngol | 2012 | https://conductscience.org/library/papers/22919396 | PubMed |
| 22028649 | Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilms. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/22028649 | PubMed |
| 21357290 | Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21357290 | PubMed |
| 19395021 | The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. | Biomaterials | 2009 | https://conductscience.org/library/papers/19395021 | PubMed |
| 19184617 | Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency. | Pharm Res | 2009 | https://conductscience.org/library/papers/19184617 | PubMed |
| 19129758 | Pulmonary fibrosis: pathogenesis, etiology and regulation. | Mucosal Immunol | 2009 | https://conductscience.org/library/papers/19129758 | PubMed |
| 18824604 | Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18824604 | PubMed |
| 17536870 | Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi. | Paediatr Drugs | 2007 | https://conductscience.org/library/papers/17536870 | PubMed |
| 14609360 | Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. | Drugs | 2003 | https://conductscience.org/library/papers/14609360 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11568993
GET https://conductscience.org/api/papers/v1/11568993/authors